Aspirin dosing for atherosclerotic cardiovascular disease: should we be more ADAPTABLE?

William A E Parker Robert F Storey

Published in: Cardiovascular research (2022)

Keyphrases

cardiovascular disease
cardiovascular events
low dose
antiplatelet therapy
type diabetes
cardiovascular risk factors
acute coronary syndrome
coronary artery disease
percutaneous coronary intervention
metabolic syndrome